Nephrology

Eur Rev Med Pharmacol Sci 2023; 27 (8): 3733-3746
DOI: 10.26355/eurrev_202304_32172

The possible role of physical activity in the modulation of gut microbiota in chronic kidney disease and its impact on cardiovascular risk: a narrative review

A. Noce, E. Tranchita, G. Marrone, E. Grazioli, M. Di Lauro, A. Murri, G. Vanni, D. Della Morte Canosci, N. Di Daniele, A. Parisi, M. Tesauro, C. Cerulli
Free PDF Download

Eur Rev Med Pharmacol Sci 2023; 27 (8): 3430-3437
DOI: 10.26355/eurrev_202304_32113

A novel risk prediction tool for contrast-induced nephropathy in patients with chronic kidney disease who underwent diagnostic coronary angiography

M. Çetin, F. Acehan, H. Kundi, I.E. Yakıcı, B. Katipoglu, G. Duran, B. Yazıcı, Z.G. Cetin, I. Ates
Free PDF Download

Eur Rev Med Pharmacol Sci 2023; 27 (8): 3396-3405
DOI: 10.26355/eurrev_202304_32110

Dexmedetomidine alleviates vacuolization and necrosis in tubular epithelial cells induced by aortic cross-clamping

S. Ergene, D. Hemsinli, S.O. Karakisi, L. Tumkaya, T. Mercantepe, A. Yılmaz
Free PDF Download

Eur Rev Med Pharmacol Sci 2023; 27 (7): 3134-3141
DOI: 10.26355/eurrev_202304_31947

Screening of Fabry Disease of patients in renal replacement therapy in a population from Lazio (Italy)

G. Marrone, R. Angelico, M. Di Lauro, E. Sargentini, T.M. Manzia, G. Tisone, A.P. Mitterhofer, D. Della Morte Canosci, M. Tesauro, N. Di Daniele, A. Noce
Free PDF Download

Eur Rev Med Pharmacol Sci 2023; 27 (6): 2469-2476
DOI: 10.26355/eurrev_202303_31780

Association of cardiometabolic risks with body composition in hemodialysis patients

N. Arslan
Free PDF Download

Eur Rev Med Pharmacol Sci 2023; 27 (4): 1413-1426
DOI: 10.26355/eurrev_202302_31379

The effect of antioxidants supplementation on oxidative stress and proinflammatory biomarkers in patients with chronic kidney disease: a systematic review and meta-analysis

R. Supriyadi, M.I.A. Koswara, M.A. Soelaeman, I. Huang
Free PDF Download

Eur Rev Med Pharmacol Sci 2023; 27 (3): 1095-1103
DOI: 10.26355/eurrev_202302_31212

Multiple factors influencing mortality in hemodialysis patients

B. Yaprak, N. Arslan, H. Alataş
Free PDF Download

Eur Rev Med Pharmacol Sci 2023; 27 (3): 893-898
DOI: 10.26355/eurrev_202302_31182

The effect of superoxide dismutase supplementation on TNF-α and TGF-β levels in patients undergoing hemodialysis

R. Supriyadi, E. Rakhmawati Kurniaatmaja, I. Huang, L. Sukesi, A. Makmun
Free PDF Download

Eur Rev Med Pharmacol Sci 2023; 27 (2): 642-648
DOI: 10.26355/eurrev_202301_31065

Systemic immune inflammation index and pan-immune inflammation value as prognostic markers in patients with idiopathic low and moderate risk membranous nephropathy

D.E. Kazan, S. Kazan
Free PDF Download

Eur Rev Med Pharmacol Sci 2022; 26 (24): 9345-9352
DOI: 10.26355/eurrev_202212_30685

Investigation of the effects of preoperative nutritional status scores on renal injury after cardiac surgery in elderly patients

S. Usta, M. Engin
Free PDF Download

Eur Rev Med Pharmacol Sci 2022; 26 (24): 9144-9156
DOI: 10.26355/eurrev_202212_30664

The nephroprotective effect of amifostine in a cecal ligation-induced sepsis model in terms of oxidative stress and inflammation

Ş. Batcik, L. Tumkaya, T. Mercantepe, M. Atak, A. Topcu, H.A. Uydu, F. Mercantepe
Free PDF Download

Eur Rev Med Pharmacol Sci 2022; 26 (24): 9079-9088
DOI: 10.26355/eurrev_202212_30657

Clinical diagnostic performance of common laboratory indicators in primary glomerulonephritis

X.-H. Li, W.-Y. Yang, J. Wang, Y.-W. Yang, C.-M. Dai, B. Zhang, J.-F. Feng
Free PDF Download

Eur Rev Med Pharmacol Sci 2022; 26 (23): 8756-8770
DOI: 10.26355/eurrev_202212_30547

A meta-analysis of effects and safety of Tripterygium wilfordii polyglycoside in the treatment of IgA nephropathy

R.-X. Wang, B.-Q. Liao, W. Chen, Y.-M. Zhang, X.-H. Tang, F.-H. Xie
Free PDF Download

Eur Rev Med Pharmacol Sci 2022; 26 (23): 8738-8755
DOI: 10.26355/eurrev_202212_30546

Carvacrol mitigates vancomycin-induced nephrotoxicity via regulation of IkBα/p38MAPK and Keap1/Nrf2 signaling pathways: an experimental study with in silico evidence

M.M. Khalaf, S.M. Hassan, A.M. Sayed, A.M. Abo-Youssef
Free PDF Download

Eur Rev Med Pharmacol Sci 2022; 26 (22): 8204-8204
DOI: 10.26355/eurrev_202211_30347

Author Correction: Antihypertensive treatment with calcium channel blockers and renal protection: focus on lercanidipine and lercanidipine/enalapril

N. Ferri, A. Corsini, R. Pontremoli
Free PDF Download

Eur Rev Med Pharmacol Sci 2022; 26 (21): 7899-7904
DOI: 10.26355/eurrev_202211_30141

A new parameter predicting steroid response in idiopathic IgA nephropathy: a pilot study of pan-immune inflammation value

O. Tunca, E.D. Kazan
Free PDF Download

Eur Rev Med Pharmacol Sci 2022; 26 (21): 7892-7898
DOI: 10.26355/eurrev_202211_30140

The effect of non-albumin proteinuria on renal outcomes in patients with biopsy proven diabetic nephropathy

S. Kazan, O. Tunca
Free PDF Download

Eur Rev Med Pharmacol Sci 2022; 26 (20): 7482-7492
DOI: 10.26355/eurrev_202210_30018

Antihypertensive treatment with calcium channel blockers and renal protection: focus on lercanidipine and lercanidipine/enalapril

N. Ferri, A. Corsini, R. Pontremoli
Free PDF Download

Eur Rev Med Pharmacol Sci 2022; 26 (19): 6985-6989
DOI: 10.26355/eurrev_202210_29881

Can expected pCO2 be calculated by pCO2=HCO3+15 formula in central venous blood gas samples?

M.E. Yuksel, S. Izdes, I. Aydar, M. Kasikci
Free PDF Download

Eur Rev Med Pharmacol Sci 2022; 26 (18): 6777-6786
DOI: 10.26355/eurrev_202209_29779

The dark side of current analytic methods for Bence Jones Proteinuria

P. Natali, G. Cigliana, C. Napodano, V. Basile, D. Debbia, K. Pocino, M. Savoia, M. Marino, F. Gulli, U. Basile
Free PDF Download